RJA
SEM

Raymond James & Associates’s Select Medical SEM Stock Holding History

Raymond James & Associates’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$9.11M Sell
484,761
-9,471
-2% -$181K 0.01% 1280
2024
Q2 		$9.34M Sell
494,232
-14,459
-3% -$247K 0.01% 1206
2024
Q1 		$8.26M Buy
508,691
+82,201
+19% +$1.2M 0.01% 1267
2023
Q4 		$5.4M Sell
426,490
-58,013
-12% -$732K ﹤0.01% 1488
2023
Q3 		$6.6M Sell
484,503
-4,727
-1% -$73K 0.01% 1285
2023
Q2 		$8.4M Buy
489,230
+647
+0.1% +$10K 0.01% 1161
2023
Q1 		$6.8M Buy
488,583
+20,776
+4% +$306K 0.01% 1262
2022
Q4 		$6.26M Buy
467,807
+8,325
+2% +$108K 0.01% 1267
2022
Q3 		$5.47M Buy
459,482
+29,352
+7% +$417K 0.01% 1319
2022
Q2 		$5.47M Buy
430,130
+20,128
+5% +$258K 0.01% 1344
2022
Q1 		$5.3M Buy
410,002
+98,884
+32% +$1.31M ﹤0.01% 1468
2021
Q4 		$4.93M Sell
311,118
-6,919
-2% -$118K ﹤0.01% 1561
2021
Q3 		$6.2M Buy
318,037
+245,848
+341% +$4.88M 0.01% 1356
2021
Q2 		$1.64M Buy
72,189
+10,347
+17% +$215K ﹤0.01% 2243
2021
Q1 		$1.14M Buy
61,842
+8,456
+16% +$139K ﹤0.01% 2417
2020
Q4 		$796K Buy
53,386
+22,946
+75% +$299K ﹤0.01% 2488
2020
Q3 		$341K Buy
+30,440
New +$300K ﹤0.01% 2874
2020
Q2 		– Sell
-23,584
Closed -$191K – 3651
2020
Q1 		$191K Sell
23,584
-58
-0.2% -$689 ﹤0.01% 3058
2019
Q4 		$297K Buy
+23,642
New +$255K ﹤0.01% 3094

Other funds holding SEM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Raymond James & Associates's SEM Position: Q3 2024 in Review

Raymond James & Associates reduced its Select Medical (SEM) stake by 1.9% in Q3 2024, selling an estimated $181K and leaving 484,761 shares worth $9.11M. The position accounts for 0.01% of the portfolio, ranked #1280.

Raymond James & Associates first reported a position in SEM in Q4 2019 and has held it in 19 quarters since. The position peaked at $9.34M in Q2 2024. 286 funds tracked by Wall St. Rank hold SEM as of Q3 2024.

  • Raymond James & Associates held 484,761 shares of Select Medical worth $9.11M as of Q3 2024.
  • Raymond James & Associates sold 9,471 Select Medical shares in Q3 2024, an estimated $181K.
  • Select Medical made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1280 holding.
  • Raymond James & Associates first reported a position in Select Medical in Q4 2019 and has held it in 19 quarters since.
  • Raymond James & Associates's Select Medical position peaked at $9.34M in Q2 2024.
  • 286 funds tracked by Wall St. Rank held Select Medical as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.